date,title,source
Oct-18-18,"Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-26-18,"Advaxis to Host Business Update Conference Call on November 2, 2018",Business Wire
Nov-06-18,Advaxis to Present Poster Entitled Natural Killer (NK) Cells Orchestrate the Antitumor Activities of Listeria monocytogenes (Lm)-Based Immunotherapy at Society for Immunotherapy of Cancer Annual Meeting,Business Wire
Nov-28-18,Advaxis to Present at LD Micro Main Event,Business Wire
Dec-12-18,Will Advaxis (ADXS) Report Negative Earnings Next Week? What You Should Know,Zacks
Dec-12-18,"Could Advaxis, Inc.s (NASDAQ:ADXS) Investor Composition Influence The Stock Price?",Simply Wall St.
Jan-08-19,"Advaxis to Host Business Update Conference Call on January 15, 2019",Business Wire
Jan-10-19,"Advaxis (ADXS) Reports Q4 Loss, Tops Revenue Estimates",Zacks
Jan-10-19,Advaxis Reports Fiscal Year 2018 Financial Results and Provides a Business Update,Business Wire
Jan-11-19,"The Daily Biotech Pulse: Agile Gives Regulatory Update On Contraceptive Patch, Advaxis Misses Estimates, Ocular Submits sNDA",Benzinga
Jan-18-19,Edited Transcript of ADXS earnings conference call or presentation 15-Jan-19 4:00pm GMT,Thomson Reuters StreetEvents
Jan-23-19,Advaxis Phase 3 AIM2CERV Study Placed on Partial Clinical Hold by FDA Related to CMC Requests,Business Wire
Jan-24-19,"Immunomodulation Bolsters Scientific Advisory Board with Appointments of Robert G. Petit, Ph.D. and Rex Chin-Wei Yung, M.D., F.C.C.P.",GlobeNewswire
Jan-24-19,"The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr's Reverse Split, Ironwood Starts Phase 1 Trial",Benzinga
Jan-25-19,Data Highlighting Potential Benefits of Lm Platform Presented at 2019 Keystone Symposia Conference on Cancer Vaccines,Business Wire
